世界のパーキンソン病薬市場：市場規模・現状・予測

• 英文タイトル：Global Parkinson Disease Drug Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7766
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、パーキンソン病薬のグローバル市場について調査・分析したレポートで、種類別（シネメットCR、Trastal、マドパー、COMT阻害剤、その他）、用途別（40歳未満、40〜65歳、65歳以上）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・パーキンソン病薬の世界市場規模
・主要企業別市場シェア
・パーキンソン病薬の世界市場規模：種類別（シネメットCR、Trastal、マドパー、COMT阻害剤、その他）
・パーキンソン病薬の世界市場規模：用途別（40歳未満、40〜65歳、65歳以上）
・パーキンソン病薬のアメリカ市場規模（種類別、用途別）
・パーキンソン病薬のヨーロッパ市場規模（種類別、用途別）
・パーキンソン病薬の中国市場規模（種類別、用途別）
・パーキンソン病薬の日本市場規模（種類別、用途別）
・パーキンソン病薬の東南アジア市場規模（種類別、用途別）
・パーキンソン病薬のインド市場規模（種類別、用途別）
・パーキンソン病薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・パーキンソン病薬の世界市場予測（2019年-2025年）
・パーキンソン病薬の地域別市場予測（2019年-2025年）
...

In 2018, the global Parkinson Disease Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Parkinson Disease Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson Disease Drug development in United States, Europe and China.

The key players covered in this study
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals

Market segment by Type, the product can be split into
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other

Market segment by Application, split into
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Parkinson Disease Drug status, future forecast, growth opportunity, key market and key players.
To present the Parkinson Disease Drug development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson Disease Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Parkinson Disease Drug Market Size Growth Rate by Type (2014-2025)
1.4.2 Sinemet-CR
1.4.3 Trastal
1.4.4 Madopar
1.4.5 COMT Inhibitor
1.4.6 Other
1.5 Market by Application
1.5.1 Global Parkinson Disease Drug Market Share by Application (2014-2025)
1.5.2 Under 40 Years Old
1.5.3 40-65 Years Old
1.5.4 Above 65 Years Old
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Parkinson Disease Drug Market Size
2.2 Parkinson Disease Drug Growth Trends by Regions
2.2.1 Parkinson Disease Drug Market Size by Regions (2014-2025)
2.2.2 Parkinson Disease Drug Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Parkinson Disease Drug Market Size by Manufacturers
3.1.1 Global Parkinson Disease Drug Revenue by Manufacturers (2014-2019)
3.1.2 Global Parkinson Disease Drug Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Parkinson Disease Drug Market Concentration Ratio (CR5 and HHI)
3.2 Parkinson Disease Drug Key Players Head office and Area Served
3.3 Key Players Parkinson Disease Drug Product/Solution/Service
3.4 Date of Enter into Parkinson Disease Drug Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Parkinson Disease Drug Market Size by Type (2014-2019)
4.2 Global Parkinson Disease Drug Market Size by Application (2014-2019)

5 United States
5.1 United States Parkinson Disease Drug Market Size (2014-2019)
5.2 Parkinson Disease Drug Key Players in United States
5.3 United States Parkinson Disease Drug Market Size by Type
5.4 United States Parkinson Disease Drug Market Size by Application

6 Europe
6.1 Europe Parkinson Disease Drug Market Size (2014-2019)
6.2 Parkinson Disease Drug Key Players in Europe
6.3 Europe Parkinson Disease Drug Market Size by Type
6.4 Europe Parkinson Disease Drug Market Size by Application

7 China
7.1 China Parkinson Disease Drug Market Size (2014-2019)
7.2 Parkinson Disease Drug Key Players in China
7.3 China Parkinson Disease Drug Market Size by Type
7.4 China Parkinson Disease Drug Market Size by Application

8 Japan
8.1 Japan Parkinson Disease Drug Market Size (2014-2019)
8.2 Parkinson Disease Drug Key Players in Japan
8.3 Japan Parkinson Disease Drug Market Size by Type
8.4 Japan Parkinson Disease Drug Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Parkinson Disease Drug Market Size (2014-2019)
9.2 Parkinson Disease Drug Key Players in Southeast Asia
9.3 Southeast Asia Parkinson Disease Drug Market Size by Type
9.4 Southeast Asia Parkinson Disease Drug Market Size by Application

10 India
10.1 India Parkinson Disease Drug Market Size (2014-2019)
10.2 Parkinson Disease Drug Key Players in India
10.3 India Parkinson Disease Drug Market Size by Type
10.4 India Parkinson Disease Drug Market Size by Application

11 Central & South America
11.1 Central & South America Parkinson Disease Drug Market Size (2014-2019)
11.2 Parkinson Disease Drug Key Players in Central & South America
11.3 Central & South America Parkinson Disease Drug Market Size by Type
11.4 Central & South America Parkinson Disease Drug Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Parkinson Disease Drug Introduction
12.1.4 Merck Revenue in Parkinson Disease Drug Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Akorn
12.2.1 Akorn Company Details
12.2.2 Company Description and Business Overview
12.2.3 Parkinson Disease Drug Introduction
12.2.4 Akorn Revenue in Parkinson Disease Drug Business (2014-2019)
12.2.5 Akorn Recent Development
12.3 GSK
12.3.1 GSK Company Details
12.3.2 Company Description and Business Overview
12.3.3 Parkinson Disease Drug Introduction
12.3.4 GSK Revenue in Parkinson Disease Drug Business (2014-2019)
12.3.5 GSK Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Parkinson Disease Drug Introduction
12.4.4 Novartis Revenue in Parkinson Disease Drug Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Company Details
12.5.2 Company Description and Business Overview
12.5.3 Parkinson Disease Drug Introduction
12.5.4 Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2014-2019)
12.5.5 Boehringer Ingelheim Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Parkinson Disease Drug Introduction
12.6.4 Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2014-2019)
12.6.5 Teva Pharmaceutical Recent Development
12.7 Abbvie
12.7.1 Abbvie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Parkinson Disease Drug Introduction
12.7.4 Abbvie Revenue in Parkinson Disease Drug Business (2014-2019)
12.7.5 Abbvie Recent Development
12.8 Kyowa Hakko Kirin Pharma
12.8.1 Kyowa Hakko Kirin Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Parkinson Disease Drug Introduction
12.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2014-2019)
12.8.5 Kyowa Hakko Kirin Pharma Recent Development
12.9 Astellas Pharma
12.9.1 Astellas Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Parkinson Disease Drug Introduction
12.9.4 Astellas Pharma Revenue in Parkinson Disease Drug Business (2014-2019)
12.9.5 Astellas Pharma Recent Development
12.10 Desitin Arzneimittel
12.10.1 Desitin Arzneimittel Company Details
12.10.2 Company Description and Business Overview
12.10.3 Parkinson Disease Drug Introduction
12.10.4 Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2014-2019)
12.10.5 Desitin Arzneimittel Recent Development
12.11 Endo Pharmaceuticals
12.12 F.Hoffmann-La Roche
12.13 H.Lundbeck
12.14 Valeant
12.15 Apokyn
12.16 Orion
12.17 Stada Arzneimittel
12.18 US WorldMeds
12.19 Valeant Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Parkinson Disease Drug Key Market Segments
Table Key Players Parkinson Disease Drug Covered
Table Global Parkinson Disease Drug Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Parkinson Disease Drug Market Size Market Share by Type 2014-2025
Figure Sinemet-CR Figures
Table Key Players of Sinemet-CR
Figure Trastal Figures
Table Key Players of Trastal
Figure Madopar Figures
Table Key Players of Madopar
Figure COMT Inhibitor Figures
Table Key Players of COMT Inhibitor
Figure Other Figures
Table Key Players of Other
Table Global Parkinson Disease Drug Market Size Growth by Application 2014-2025 (Million US$)
Figure Under 40 Years Old Case Studies
Figure 40-65 Years Old Case Studies
Figure Above 65 Years Old Case Studies
Figure Parkinson Disease Drug Report Years Considered
Table Global Parkinson Disease Drug Market Size 2014-2025 (Million US$)
Figure Global Parkinson Disease Drug Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Parkinson Disease Drug Market Size by Regions 2014-2025 (Million US$)
Table Global Parkinson Disease Drug Market Size by Regions 2014-2019 (Million US$)
Table Global Parkinson Disease Drug Market Share by Regions 2014-2019
Figure Global Parkinson Disease Drug Market Share by Regions 2014-2019
Figure Global Parkinson Disease Drug Market Share by Regions 2019
Table Market Top Trends
Table Global Parkinson Disease Drug Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Parkinson Disease Drug Market Share by Manufacturers (2014-2019)
Figure Global Parkinson Disease Drug Market Share by Manufacturers in 2018
Table Global Parkinson Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Parkinson Disease Drug Product/Solution/Service
Table Date of Enter into Parkinson Disease Drug Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
Table Global Parkinson Disease Drug Market Size Share by Type (2014-2019)
Figure Global Parkinson Disease Drug Market Size Market Share by Type (2014-2019)
Table Global Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
Table Global Parkinson Disease Drug Market Size Share by Application (2014-2019)
Figure Global Parkinson Disease Drug Market Size Market Share by Application (2014-2019)
Figure Global Parkinson Disease Drug Revenue Market Share by Application in 2018
Figure United States Parkinson Disease Drug Market Size 2014-2019 (Million US$)
Table United States Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
Table United States Key Players Parkinson Disease Drug Market Share (2018-2019)
Table United States Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
Table United States Parkinson Disease Drug Market Share by Type (2014-2019)
Table United States Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
Table United States Parkinson Disease Drug Market Share by Application (2014-2019)
Figure Europe Parkinson Disease Drug Market Size 2014-2019 (Million US$)
Table Europe Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
Table Europe Key Players Parkinson Disease Drug Market Share (2018-2019)
Table Europe Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
Table Europe Parkinson Disease Drug Market Share by Type (2014-2019)
Table Europe Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
Table Europe Parkinson Disease Drug Market Share by Application (2014-2019)
Figure China Parkinson Disease Drug Market Size 2014-2019 (Million US$)
Table China Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
Table China Key Players Parkinson Disease Drug Market Share (2018-2019)
Table China Parkinson Disease Drug Market Size by Type (2014-20189) (Million US$)
Table China Parkinson Disease Drug Market Share by Type (2014-2019)
Table China Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
Table China Parkinson Disease Drug Market Share by Application (2014-2019)
Figure Japan Parkinson Disease Drug Market Size 2014-2019 (Million US$)
Table Japan Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
Table Japan Key Players Parkinson Disease Drug Market Share (2018-2019)
Table Japan Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
Table Japan Parkinson Disease Drug Market Share by Type (2014-2019)
Table Japan Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
Table Japan Parkinson Disease Drug Market Share by Application (2014-2019)
Figure Southeast Asia Parkinson Disease Drug Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Parkinson Disease Drug Market Share (2018-2019)
Table Southeast Asia Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Parkinson Disease Drug Market Share by Type (2014-2019)
Table Southeast Asia Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Parkinson Disease Drug Market Share by Application (2014-2019)
Figure India Parkinson Disease Drug Market Size 2014-2019 (Million US$)
Table India Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
Table India Key Players Parkinson Disease Drug Market Share (2018-2019)
Table India Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
Table India Parkinson Disease Drug Market Share by Type (2014-2019)
Table India Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
Table India Parkinson Disease Drug Market Share by Application (2014-2019)
Figure Central & South America Parkinson Disease Drug Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Parkinson Disease Drug Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Parkinson Disease Drug Market Share (2018-2019)
Table Central & South America Parkinson Disease Drug Market Size by Type (2014-2019) (Million US$)
Table Central & South America Parkinson Disease Drug Market Share by Type (2014-2019)
Table Central & South America Parkinson Disease Drug Market Size by Application (2014-2019) (Million US$)
Table Central & South America Parkinson Disease Drug Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Parkinson Disease Drug Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table Merck Recent Development
Table Akorn Company Details
Table Akorn Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
Figure Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table Akorn Recent Development
Table GSK Company Details
Table GSK Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table Novartis Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table Abbvie Recent Development
Table Kyowa Hakko Kirin Pharma Company Details
Table Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table Kyowa Hakko Kirin Pharma Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table Astellas Pharma Recent Development
Table Desitin Arzneimittel Company Details
Table Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2014-2019)(Million US$)
Figure Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2014-2019)
Table Desitin Arzneimittel Recent Development
Table Endo Pharmaceuticals Company Details
Table F.Hoffmann-La Roche Company Details
Table H.Lundbeck Company Details
Table Valeant Company Details
Table Apokyn Company Details
Table Orion Company Details
Table Stada Arzneimittel Company Details
Table US WorldMeds Company Details
Table Valeant Pharmaceuticals Company Details
Table Global Parkinson Disease Drug Market Size by Regions (Million US$) 2019-2025
Figure Global Parkinson Disease Drug Market Size Share by Regions (2019-2025)
Figure Global Parkinson Disease Drug Market Size Share by Regions in 2025
Figure United States Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
Figure Europe Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
Figure China Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
Figure Japan Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
Figure India Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Parkinson Disease Drug Market Size Forecast (2019-2025)(Million USD)
Table Global Parkinson Disease Drug Market Size by Product (2019-2025) (Million US$)
Figure Global Parkinson Disease Drug Market Size by Product (2019-2025)
Figure Global Parkinson Disease Drug Market Size by Product in 2025
Table Global Parkinson Disease Drug Market Size by Application (2019-2025) (Million US$)
Figure Global Parkinson Disease Drug Market Size by Application (2019-2025)
Figure Global Parkinson Disease Drug Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界のクッシング病治療市場：市場規模・現状・予測

Global Cushing’s Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N7048 2019年6月14日 94Pages
当資料は、クッシング病治療のグローバル市場について調査・分析したレポートで、種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、その他）、用途別（病院薬局、小売薬局、ドラッグストア、診療所、Eコマース/オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東...

世界の疾患リスクと健康診断市場：市場規模・現状・予測

Global Disease Risk and Health Test Market Size, Status and Forecast 2019-2025
QYR9N7121 2019年6月14日 118Pages
当資料は、疾患リスクと健康診断のグローバル市場について調査・分析したレポートで、種類別（セリアック病、パーキンソン病、アルツハイマー病、その他）、用途別（オンライン、オフライン）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...

世界の病気のリスクと健康に関する遺伝子検査市場：市場規模・現状・予測

Global Disease Risk and Health Genetic Test Market Size, Status and Forecast 2019-2025
QYR9N7120 2019年6月14日 115Pages
当資料は、病気のリスクと健康に関する遺伝子検査のグローバル市場について調査・分析したレポートで、種類別（セリアック病、パーキンソン病、アルツハイマー病、その他）、用途別（オンライン、オフライン）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...

世界のクローン病市場：市場規模・現状・予測

Global Crohn's Disease Market Size, Status and Forecast 2019-2025
QYR9N7042 2019年6月14日 99Pages
当資料は、クローン病のグローバル市場について調査・分析したレポートで、種類別（手術、薬物療法）、用途別（病院、外来手術センター、その他、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・...

世界の消費者向け疾病リスクと健康診断市場：市場規模・現状・予測

Global Direct-to-consumer Disease Risk and Health Test Market Size, Status and Forecast 2019-2025
QYR9N7114 2019年6月14日 118Pages
当資料は、消費者向け疾病リスクと健康診断のグローバル市場について調査・分析したレポートで、種類別（セリアック病、パーキンソン病、アルツハイマー病、その他）、用途別（オンライン、オフライン）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界の鎌状赤血球症薬と関連した血管閉塞性の危機市場2019

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Market Report 2019
QYR9N5462 2019年6月14日 103Pages
本調査レポートでは、鎌状赤血球症薬と関連した血管閉塞性の危機の世界市場について調査・分析し、鎌状赤血球症薬と関連した血管閉塞性の危機のメーカー別販売量、市場シェア分析、種類別販売分析（SGD-2083、クリザンリズマブ、PF-04447943、NVX-508、その他）、用途別販売分析（診療所、病院、...

世界のスニチニブ薬市場：市場規模・現状・予測

Global Sunitinib Drug Market Size, Status and Forecast 2019-2025
QYR9N8092 2019年6月14日 92Pages
当資料は、スニチニブ薬のグローバル市場について調査・分析したレポートで、種類別（12.5 mgのカプセル、25 mgカプセル、37.5 mgカプセル、50 mgカプセル）、用途別（腎臓がん、GIST、pNET）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市...

世界のアルツハイマー病に関連する認知症市場：市場規模・現状・予測

Global Dementia Associated with Alzimer’s Disease Market Size, Status and Forecast 2019-2025
QYR9N7075 2019年6月14日 96Pages
当資料は、アルツハイマー病に関連する認知症のグローバル市場について調査・分析したレポートで、種類別（コリン作動性/コリンエステラーゼ（ChE）阻害剤、メマンチン、配合薬（メマンチン＆ドネペジル）、その他）、用途別（病院薬局、小売、オンライン販売）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南ア...

世界のフォンヴィレブランド病治療市場：市場規模・現状・予測

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N8188 2019年6月14日 93Pages
当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界のポイントオブケア感染症診断市場：市場規模・現状・予測

Global Point-of-care Infectious Disease Diagnostics Market Size, Status and Forecast 2019-2025
QYR9N7854 2019年6月14日 99Pages
当資料は、ポイントオブケア感染症診断のグローバル市場について調査・分析したレポートで、種類別（HIV POC、クロストリジウムディフィシルPOC、HBV POC、RSウイルスPOC、HPV POC、その他）、用途別（病院、診療所、ホーム、生活支援医療施設、実験室、その他）、主要地域別（アメリカ、ヨー...

世界のクッシング病治療市場：市場規模・現状・予測 Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
世界のスニチニブ薬市場：市場規模・現状・予測 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界のレボセチリジン薬市場：市場規模・現状・予測 Levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. It is also used to relieve itching and hives. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction.In 2018, t…
世界の疾患リスクと健康診断市場：市場規模・現状・予測 The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrie…
世界のクローン病市場：市場規模・現状・予測 Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Cr…